Reyes L, Naser L, Weiner W, Thifault D, Stahl E, McCreary L
Nat Commun. 2025; 16(1):2060.
PMID: 40021642
PMC: 11871066.
DOI: 10.1038/s41467-025-57196-9.
Alvarado C, Stahl E, Koessel K, Rivera A, Cherry B, Pulavarti S
Molecules. 2019; 24(18).
PMID: 31540099
PMC: 6766811.
DOI: 10.3390/molecules24183352.
Marlowe T, Alvarado C, Rivera A, Lenzo F, Nott R, Bondugji D
SLAS Discov. 2019; 25(1):21-32.
PMID: 31513463
PMC: 9590608.
DOI: 10.1177/2472555219874313.
Nolasco-Quiroga M, Rosas-Diaz M, Moreno J, Godinez-Aguilar R, Lopez-Ibarra M, Pina-Sanchez P
Oncol Lett. 2019; 17(6):4779-4786.
PMID: 31186683
PMC: 6507456.
DOI: 10.3892/ol.2019.10147.
Hernandez-Corbacho M, Canals D, Adada M, Liu M, Senkal C, Yi J
J Biol Chem. 2015; 290(42):25356-73.
PMID: 26318452
PMC: 4646185.
DOI: 10.1074/jbc.M115.658658.
Emerging roles of focal adhesion kinase in cancer.
Tai Y, Chen L, Shen T
Biomed Res Int. 2015; 2015:690690.
PMID: 25918719
PMC: 4396139.
DOI: 10.1155/2015/690690.
Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
Gillory L, Stewart J, Megison M, Waters A, Beierle E
J Surg Res. 2015; 196(2):339-49.
PMID: 25862488
PMC: 4442704.
DOI: 10.1016/j.jss.2015.03.021.
A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
Kurenova E, Ucar D, Liao J, Yemma M, Gogate P, Bshara W
Cell Cycle. 2014; 13(16):2542-53.
PMID: 25486195
PMC: 4614818.
DOI: 10.4161/15384101.2015.941760.
Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.
Yoon H, Dehart J, Murphy J, Lim S
J Histochem Cytochem. 2014; 63(2):114-28.
PMID: 25380750
PMC: 4305513.
DOI: 10.1369/0022155414561498.
Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus.
Hendry W, Hariri H, Alwis I, Gunewardena S, Hendry I
Reprod Toxicol. 2014; 50:68-86.
PMID: 25242112
PMC: 4261067.
DOI: 10.1016/j.reprotox.2014.09.002.
Targeting the p53 pathway.
Golubovskaya V, Cance W
Surg Oncol Clin N Am. 2013; 22(4):747-64.
PMID: 24012397
PMC: 3810242.
DOI: 10.1016/j.soc.2013.06.003.
Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
Stewart J, Ma X, Megison M, Nabers H, Cance W, Kurenova E
Mol Carcinog. 2013; 54(1):9-23.
PMID: 23868727
PMC: 4370318.
DOI: 10.1002/mc.22070.
MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells.
Golubovskaya V, Sumbler B, Ho B, Yemma M, Cance W
Anticancer Agents Med Chem. 2013; 14(1):18-28.
PMID: 23438844
PMC: 3883917.
DOI: 10.2174/187152061401140108113435.
FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
Megison M, Stewart J, Nabers H, Gillory L, Beierle E
Clin Exp Metastasis. 2012; 30(5):555-68.
PMID: 23208732
PMC: 3625446.
DOI: 10.1007/s10585-012-9560-7.
Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.
Beierle E, Ma X, Stewart J, Megison M, Cance W, Kurenova E
Mol Carcinog. 2012; 53(3):230-42.
PMID: 23065847
PMC: 3809027.
DOI: 10.1002/mc.21969.
Cell survival signaling in neuroblastoma.
Megison M, Gillory L, Beierle E
Anticancer Agents Med Chem. 2012; 13(4):563-75.
PMID: 22934706
PMC: 3710698.
DOI: 10.2174/1871520611313040005.
Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP.
Sanchez A, Flamini M, Baldacci C, Goglia L, Genazzani A, Simoncini T
Mol Endocrinol. 2010; 24(11):2114-25.
PMID: 20880986
PMC: 5417375.
DOI: 10.1210/me.2010-0252.
Focal adhesion kinase and p53 signal transduction pathways in cancer.
Golubovskaya V, Cance W
Front Biosci (Landmark Ed). 2010; 15(3):901-12.
PMID: 20515733
PMC: 3136041.
DOI: 10.2741/3653.
Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
Beierle E, Ma X, Stewart J, Nyberg C, Trujillo A, Cance W
Cell Cycle. 2010; 9(5):1005-15.
PMID: 20160475
PMC: 2855768.
DOI: 10.4161/cc.9.5.10936.
Suppression of human MDA-MB-435S tumor by U6 promoter-driven short hairpin RNAs targeting focal adhesion kinase.
Huang A, Wan Y, Liao D, Hu H, Wei L, Wang X
J Cancer Res Clin Oncol. 2010; 136(8):1229-42.
PMID: 20140743
DOI: 10.1007/s00432-010-0773-3.